Press release
Growing Emphasis On Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomic Technologies Driving Market Acceleration in the T Cell Specific Surface Glycoprotein CD28 Industry, 2025
T Cell Specific Surface Glycoprotein CD28 Market
How Large Will the T Cell Specific Surface Glycoprotein CD28 Market Size By 2025?
In recent times, the market for the T cell-specific surface glycoprotein known as CD28 has expanded at a brisk pace. Forecasts suggest an increase from $1.47 billion in 2024 to approximately $1.62 billion in 2025, embodying a compound annual growth rate (CAGR) of 10.1%. This historical growth is largely due to factors such as the increased focus on immunotherapy research, a surge in cancer prevalence, more reported instances of autoimmune diseases, augmented number of clinical trials, and a growing preference for monoclonal antibodies.
How Big Is the T Cell Specific Surface Glycoprotein CD28 Market Size Expected to Grow by 2029?
In the coming years, the market for the T cell-specific surface glycoprotein CD28 is predicted to observe robust growth, reaching $2.35 billion by 2029 with a compound annual growth rate (CAGR) of 9.8%. This boost in market growth during the forecasted period can be credited to the escalating demand for personalized medicine and the increasing emphasis on T-cell-based therapies. Other contributing elements include the growing consciousness of immuno-oncology, a burgeoning pipeline of targeted treatments, considerable investment by pharmaceutical companies, and the burgeoning applications for chronic diseases. Notable market trends during this period include advancements in cell engineering techniques, the progressive development of bispecific antibodies, innovation in specific immunotherapies, the incorporation of AI in medication discovery, and progress in biologics manufacturing.
View the full report here:
https://www.thebusinessresearchcompany.com/report/t-cell-specific-surface-glycoprotein-cd28-global-market-report
Which Key Market Drivers Powering T Cell Specific Surface Glycoprotein CD28 Market Expansion and Growth?
The surge in focus on personalized medicine is anticipated to boost the T cell-specific surface glycoprotein CD28 market's expansion. Personalized medicine is a healthcare strategy that customizes treatments according to each patient's genetics, environment, and lifestyle for optimized results and enhanced care. The call for personalized medicine is rising due to technological advancements in genomics, permitting the accurate detection of genetic discrepancies and personalized treatments for individuals. The T cell-specific surface glycoprotein CD28 bolsters personalized medicine by facilitating targeted immune modulation, hence increasing the precision and efficacy of therapies. It augments treatment results by triggering optimal T cell activation and enhancing patient-specific immune responses. For example, in February 2024, as per the Personalized Medicine Coalition (PMC), a non-profit organization based in the US, the U.S. Food and Drug Administration (FDA) gave approval to 26 new personalized medicines in 2023, a rise from 12 approved in 2022. Thus, the heightened focus on personalized medicine is propelling the growth of the T cell-specific surface glycoprotein CD28 market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27429&type=smp
What Are the Key Trends Driving T Cell Specific Surface Glycoprotein CD28 Market Growth?
Leading firms working in the T cell-specific surface glycoprotein CD28 market are concentrating on the development of ground-breaking products like combination immunotherapies to increase T cell stimulation, anti-tumor efficiency, and improve the results of patient treatment. Combination immunotherapies are therapeutic methods that utilize multiple immune-oriented strategies to strengthen the body's disease resistance. For example, in February 2025, a US biopharmaceutical organization, Rondo Therapeutics Inc., unveiled preclinical results for RNDO 564, an innovative CD28 Nectin 4 costimulatory bispecific antibody for pervasive bladder cancer. The product is designed to selectively trigger CD28 on T cells when binding to Nectin-4-expressing cancer cells, amplifying T-cell-mediated tumor destruction while reducing unwanted toxicity. The released data show powerful anti-tumor effects in preclinical scenarios, advocating further progression as a possible cure for patients living with metastatic urothelial carcinoma.
What Are the Emerging Segments in the T Cell Specific Surface Glycoprotein CD28 Market?
The t cell specific surface glycoprotein cd28 market covered in this report is segmented
1) By Type: FPT 155, FR 104, Lulizumab Pegol, Other Types
2) By Technology: Flow Cytometry, EnzymeLinked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), Weste Blotting, Immunohistochemistry
3) By Distribution Channel: Direct Sales, Distributors, Ecommerce, Retail Pharmacies, Wholesalers
4) By Application: Immunology Research, Cancer Research, Autoimmune Diseases, Infectious Diseases, Stem Cell Research
5) By End-User: Hospitals, Research Laboratories, Academic Institutions, Pharmaceutical Companies, Diagnostic Laboratories
Subsegments:
1) By FPT 155: Preclinical Studies, Clinical Trials, Oncology Applications, Licensing And Partnerships
2) By FR 104: Autoimmune Disease Applications, Rheumatoid Arthritis Trials, Transplant Rejection Studies, Research Collaborations
3) By Lulizumab Pegol: Systemic Lupus Erythematosus (SLE) Studies, Immunomodulation Research, Biopharmaceutical Development, Monoclonal Antibody Engineering
4) By Other Types: Novel CD28 Inhibitors, Combination Therapies, Biosimilars And Biobetters, Emerging Research Compounds
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27429&type=smp
Who Are the Global Leaders in the T Cell Specific Surface Glycoprotein CD28 Market?
Major companies operating in the t cell specific surface glycoprotein cd28 market are Gilead Sciences Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Becton dic*kinson and Company, Regeneron Pharmaceuticals Inc., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Sino Biological Inc., Xencor Inc., ACROBiosystems Co. Ltd., Fate Therapeutics Inc., Medigene AG, Alpine Immune Sciences Inc., Adaptimmune Therapeutics plc, OSE Immunotherapeutics SA, Creative Biolabs Inc., Rondo Therapeutics Inc.
Which are the Top Profitable Regional Markets for the T Cell Specific Surface Glycoprotein CD28 Industry?
North America was the largest region in the T cell-specific surface glycoprotein CD28 market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the t cell specific surface glycoprotein cd28 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27429
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growing Emphasis On Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomic Technologies Driving Market Acceleration in the T Cell Specific Surface Glycoprotein CD28 Industry, 2025 here
News-ID: 4171101 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for CD28
T Cell-specific Surface Glycoprotein CD28 Antibody Market is estimated to reach …
" The global market for T Cell-specific Surface Glycoprotein CD28 Antibodies is valued at approximately $1.5 billion in 2024. It is projected to grow significantly, reaching an estimated $3.6 billion by 2034, driven by an increasing focus on immunotherapy and the rising prevalence of cancers and autoimmune diseases. The Compound Annual Growth Rate (CAGR) for this market during the forecast period from 2025 to 2034 is forecasted at around 9.5%."
Exactitude…
T-Cell Specific Surface Glycoprotein CD28 Market Booming Worldwide with Latest T …
T-cell specific surface glycoprotein CD28 market is anticipated to grow at a significant CAGR during the forecast period. CD28 is a glycoprotein of 90 kDa and occurs naturally as a disulfide-linked homodimer of a polypeptide that contains a single Ig-like extracellular domain. Additionally, it is a member of the Ig superfamily and is expressed on T cells that provide co-stimulatory signals which are required for T cell activation and survival.…
Trending Report on T Cell Specific Surface Glycoprotein CD28 Market 2023-2030 Bu …
The "Global T Cell Specific Surface Glycoprotein CD28 Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the T Cell Specific Surface Glycoprotein CD28 industry along with various other factors over the predicted period 2023-2030. The report on the T Cell Specific Surface Glycoprotein CD28 market is focusing on a series of parameters including top manufacturing…
Global CD28 (Antibody) Market- Size, Share, Analysis, and Trends, 2020-2029
Dhirtek Business Research and Consulting most recent study on the cd28 (antibody) market provides a comprehensive view of the entire market. The research report delves deeply into the global cd28 (antibody) market's drivers and restraints. Analysts have extensively researched the global cd28 (antibody) market's milestones and the current trends that are expected to determine its future. Primary and secondary research methods were used to create an in-depth report on the…
T-Cell Specific Surface Glycoprotein CD28 Market 2021 Analysis May Set New Growt …
The global T-cell specific surface glycoprotein CD28 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). CD28 is a glycoprotein of 90 kDa and occurs naturally as a disulfide-linked homodimer of a polypeptide that contains a single Ig-like extracellular domain. Additionally, it is a member of the Ig superfamily and is expressed on T cells that provide co-stimulatory signals which are required for T cell…
T Cell Specific Surface Glycoprotein CD28 Market Business Opportunities 2026 - T …
T Cell Specific Surface Glycoprotein CD28 Market
UpMarketResearch, 02-04-2020: The research report on the T Cell Specific Surface Glycoprotein CD28 Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future…
